Articles from Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Gábor v. Transocean Ltd., et al., Case No. 1:24-cv-09964, on behalf of persons and entities that purchased or otherwise acquired Transocean Ltd. (“Transocean” or the “Company”) (NYSE: RIG,) securities between October 31, 2023 and September 2, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSESUI) securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired MGP Ingredients, Inc. (“MGPI” or the “Company”) (NASDAQMGPI) common stock between May 4, 2023 through October 30, 2024,, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSESUI) securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”). Sun Communities investors have until February 10, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired MGP Ingredients, Inc. (“MGPI” or the “Company”) (NASDAQMGPI) common stock between May 4, 2023 through October 30, 2024, inclusive (the “Class Period”). MGPI investors have until February 14, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s February 2024 initial public offering (the “IPO” or the “Offering”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) securities between June 4, 2024 and August 8, 2024,, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 4, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired DMC Global Inc. (“DMC” or the “Company”) (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s February 2024 initial public offering (the “IPO” or the “Offering”). Kyverna investors have until February 7, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024 and November 4, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) securities between June 4, 2024 and August 8, 2024, inclusive (the “Class Period”). Five9 investors have until February 3, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 31, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024 and November 4, 2024, inclusive (the “Class Period”). Marqeta investors have until February 7, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DMC Global Inc. (“DMC” or the “Company”) (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024, inclusive (the “Class Period”). DMC investors have until February 4, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”). Customers Bancorp investors have until January 31, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”). Aehr investors have until February 3, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of The Beauty Health Company (NASDAQSKIN) f/k/a Vesper Healthcare Acquisition Corp. concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of NuScale Power Corporation (NYSESMR) f/k/a Spring Valley Acquisition Corp. concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Corredor v. ASP Isotopes Inc., et al., Case No. 24-cv-09253, on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). Symbotic investors have until February 3, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 24, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Match Group, Inc. (“Match Group” or the “Company”) (NASDAQMTCH) securities between May 2, 2023 and November 6, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”). Rentokil investors have until January 27, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQASPI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQCELH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Match Group, Inc. (“Match Group” or the “Company”) (NASDAQMTCH) securities between May 2, 2023 and November 6, 2024, inclusive (the “Class Period”). Match Group investors have until January 24, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSEWOLF) securities between August 16, 2023 and November 6, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Franklin Resources, Inc. (“Franklin” or the “Company”) (NYSEBEN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQICLR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQREGN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Macy’s, Inc. (“Macy’s” or the “Company”) (NYSEM) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of ChargePoint Holdings, Inc. (NYSECHPT) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSEWOLF) securities between August 16, 2023 and November 6, 2024, inclusive (the “Class Period”). Wolfspeed investors have until January 17, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA) securities between February 27, 2024 and November 13, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of SolarWinds Corporation (NYSESWI) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSEMAX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Triumph Group, Inc. (NYSETGI) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of TruBridge, Inc. (f//k/a Computer Programs and Systems, Inc.) (Nasdaq: TBRG) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Davoodi v. Zeta Global Holdings Corp., et al., Case No. 24-cv-8961, on behalf of persons and entities that purchased or otherwise acquired Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA) securities between February 27, 2024 and November 13, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSEWOLF) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired TMC the metals company Inc. (“TMC” or the “Company”) (NASDAQTMC) securities between May 12, 2023 and March 25, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Chipotle Mexican Grill, Inc. (“Chipotle” or the “Company”) (NYSECMG) common stock between February 8, 2024 and October 29, 2024, inclusive (the “Class Period”) and those who purchased Chipotle call options or sold put options during the class period.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 13, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQHAS) common stock between February 7, 2022, and October 25, 2023, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 13, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ASML Holding N.V. (“ASML” or the “Company”) (NASDAQASML) ordinary shares between January 24, 2024, and October 15, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQHUMA) securities between May 10, 2024 and October 17, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX) securities between January 25, 2024 and October 28, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired TMC the metals company Inc. (“TMC” or the “Company”) (NASDAQTMC) securities between May 12, 2023 and March 25, 2024, inclusive (the “Class Period”). TMC investors have until January 7, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQHAS) common stock between February 7, 2022, and October 25, 2023, inclusive (the “Class Period”). Hasbro investors have until January 13, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Chipotle Mexican Grill, Inc. (“Chipotle” or the “Company”) (NYSECMG) common stock between February 8, 2024 and October 29, 2024, inclusive (the “Class Period”) and those who purchased Chipotle call options or sold put options during the class period. Chipotle investors have until January 10, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Wilson v. Xerox Holding Corporation, et al., Case No. 24-cv-8809, on behalf of persons and entities that purchased or otherwise acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX) securities between January 25, 2024 and October 28, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ASML Holding N.V. (“ASML” or the “Company”) (NASDAQASML) ordinary shares between January 24, 2024, and October 15, 2024, inclusive (the “Class Period”). ASML investors have until January 13, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Middle District of North Carolina, captioned Cutshall v. Humacyte, Inc., et al., Case No. 1:24-cv-00954, on behalf of persons and entities that purchased or otherwise acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQHUMA) securities between May 10, 2024 and October 17, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQHAS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 13, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of PACS Group, Inc. (“PACS Group” or the “Company”) (NYSEPACS) investors who purchased: (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 11, 2024 initial public offering (“IPO” or the “Offering”); and/or (b) securities between April 11, 2024 and November 5, 2024 inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQICLR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Chipotle Mexican Grill, Inc. (“Chipotle” or the “Company”) (NYSECMG) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Match Group, Inc. (“Match” or the “Company”) (NASDAQMTCH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of TMC the metals company Inc. (“TMC” or the “Company”) (NASDAQTMC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Mynaric AG (“Mynaric” or the “Company”) (NASDAQMYNA) securities between June 20, 2024 and October 7, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 31, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Flux Power Holdings, Inc. (“Flux Power” or the “Company”) (NASDAQFLUX) securities between November 11, 2022 and September 30, 2024, inclusive (the “Class Period”).